Center for Mendelian Genomics, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Hum Mutat. 2018 Dec;39(12):1827-1834. doi: 10.1002/humu.23655. Epub 2018 Oct 3.
Rare disease investigators constantly face challenges in identifying additional cases to build evidence for gene-disease causality. The Matchmaker Exchange (MME) addresses this limitation by providing a mechanism for matching patients across genomic centers via a federated network. The MME has revolutionized searching for additional cases by making it possible to query across institutional boundaries, so that what was once a laborious and manual process of contacting researchers is now automated and computable. However, while the MME network is beginning to scale, the growth of additional nodes is limited by the lack of easy-to-use solutions that can be implemented by any rare disease database owner, even one without significant software engineering resources. Here, we describe matchbox, which is an open-source, platform-independent, portable bridge between any given rare disease genomic center and the MME network, which has already led to novel gene discoveries. We also describe how matchbox greatly reduces the barrier to participation by overcoming challenges for new databases to join the MME.
罕见病研究人员在确定额外病例以建立基因-疾病因果关系的证据时,经常面临挑战。Matchmaker Exchange (MME) 通过提供一种通过联合网络在基因组中心之间匹配患者的机制来解决这一限制。MME 通过使跨机构边界查询成为可能,从而彻底改变了寻找额外病例的方式,使得曾经是一项繁琐和手动的联系研究人员的过程自动化和可计算化。然而,尽管 MME 网络开始扩展,但由于缺乏任何罕见病数据库所有者(即使是没有重要软件工程资源的所有者)都可以实施的易用解决方案,因此增加节点的数量受到限制。在这里,我们描述了 matchbox,它是一个开源的、与平台无关的、可移植的桥梁,连接任何给定的罕见病基因组中心和 MME 网络,它已经导致了新的基因发现。我们还描述了 matchbox 如何通过克服新数据库加入 MME 的挑战,大大降低了参与的门槛。